Related references
Note: Only part of the references are listed.Structural basis of HIV-1 resistance to AZT by excision
Xiongying Tu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
Kamalendra Singh et al.
VIRUSES-BASEL (2010)
Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
Kalyan Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor
Eleftherios Michailidis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Comparison of HIV-1 Drug Susceptibility as Provided by Conventional Phenotyping and by a Phenotype Prediction Tool Based on Viral Genotype
Margriet Van Houtte et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
Stefan G. Sarafianos et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data
Bart Winters et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation
C. Delaugerre et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
Atsuko Hachiya et al.
JOURNAL OF VIROLOGY (2008)
Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase
Luis Menendez-Arias
VIRUS RESEARCH (2008)
Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to zidovudine and other nucleoside analog inhibitors in vitro
Robert A. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Broad Antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)
Kazuya Shimura et al.
JOURNAL OF VIROLOGY (2008)
In vitro suppression of K65R reverse transcriptase-mediated tenofovir- and adefovir-5′-diphosphate resistance conferred by the boranophosphonate derivatives
Antoine Frangeul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
R. M. Kagan et al.
ANTIVIRAL RESEARCH (2007)
Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways
Kristel Van Laethem et al.
INFECTION GENETICS AND EVOLUTION (2007)
Participation of the fingers subdomain of Escherichia coli DNA polymerase I in the strand displacement synthesis of DNA
Kamalendra Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Long-term follow-up of patients taking tenofovir DF with low-level HIV-1 viremia and the K65R substitution in HIV-1 RT
Brandi J. Chappell et al.
AIDS (2007)
Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the β3-β4 hairpin loop in dNTP selection
Scott J. Garforth et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors
Nicolas Sluis-Cremer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine
JY Feng et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase
FA Frankel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (-)-β-D-1′, 3′-dioxolan guanine
JY Feng et al.
ANTIVIRAL RESEARCH (2005)
Crystal structures of HIV-1 reverse transcriptases mutated at Codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors
J Ren et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
SG Sarafianos et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2004)
A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions
J Deval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain -: Effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNA primers
T Matamoros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
S Tuske et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants
S Matsumi et al.
AIDS (2003)
Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation
PR Meyer et al.
JOURNAL OF VIROLOGY (2003)
The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1
DJ McColl et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using α-boranophosphate nucleotide analogues
J Deval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision
PL Boyer et al.
JOURNAL OF VIROLOGY (2002)
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF
NA Margot et al.
AIDS (2002)
Primer unblocking and rescue of DNA synthesis by azidothymidine (AZT)-resistant HIV-1 reverse transcriptase - Comparison between initiation and elongation of reverse transcription and between (-) and (+) strand DNA synthesis
M Rigourd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
PL Boyer et al.
JOURNAL OF VIROLOGY (2001)
Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4+ cell clone 1-10 (MAGIC-5)
A Hachiya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples
MD Miller et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance
A Mas et al.
EMBO JOURNAL (2000)
The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase
HQ Gao et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy
PR Harrigan et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
